Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR1 | P32246 | 5/20 | 1.00 |
| ▸ | CCR8 | P51685 | 5/20 | 1.00 |
| ▸ | LMNA | P02545 | 4/20 | 1.00 |
| ▸ | CCR5 | P51681 | 3/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 1.00 |
| ▸ | MMP2 | P08253 | 2/20 | 1.00 |
| ▸ | TSHR | P16473 | 2/20 | 1.00 |
| ▸ | MAPT | P10636 | 2/20 | 1.00 |
| ▸ | HTT | P42858 | 2/20 | 1.00 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 1.00 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 1.00 |
| ▸ | GMNN | O75496 | 1/20 | 1.00 |
| ▸ | TP53 | P04637 | 1/20 | 1.00 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 1/20 | 1.00 |
| ▸ | CYP2D6 | P10635 | 1/20 | 1.00 |
| ▸ | MMP9 | P14780 | 1/20 | 1.00 |
| ▸ | ALOX15 | P16050 | 1/20 | 1.00 |
| ▸ | NFKB1 | P19838 | 1/20 | 1.00 |
| ▸ | MMP8 | P22894 | 1/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phenanthroline SCHEMBL8845760 | 1.00 | CCR1 (1.00) | CCR1CCR8LMNACCR5KDM4E | |
| Phenanthroline SCHEMBL8312 | 1.00 | CCR1 (1.00) | CCR1CCR8LMNACCR5KDM4E | |
| Phenanthroline SCHEMBL29367277 | 1.00 | CCR1 (1.00) | CCR1CCR8LMNACCR5KDM4E | |
| Phenanthroline SCHEMBL21060516 | 0.97 | CCR1 (0.94) | CCR1CCR8LMNACCR5KDM4E | |
| Phenanthroline SCHEMBL22462277 | 0.97 | CCR1 (0.94) | CCR1CCR8LMNACCR5KDM4E | |
| Phenanthroline SCHEMBL22982126 | 0.97 | CCR1 (0.94) | CCR1CCR8LMNACCR5KDM4E | |
| Phenanthroline SCHEMBL21300488 | 0.97 | CCR1 (0.94) | CCR1CCR8LMNACCR5KDM4E | |
| Phenanthroline SCHEMBL21044608 | 0.97 | CCR1 (0.94) | CCR1CCR8LMNACCR5KDM4E | |
| Phenanthroline SCHEMBL3790396 | 0.97 | CCR1 (0.94) | CCR1CCR8LMNACCR5KDM4E | |
| Phenanthroline SCHEMBL345410 | 0.97 | CCR1 (0.94) | CCR1CCR8LMNACCR5KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1369 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4406387-B1 | AN ORGANIC ELECTRONIC DEVICE COMPRISING A SUBSTRATE, AN ANODE LAYER, A CATHODE LAYER, AT LEAST ONE FIRST EMISSION LAYER, AND A HOLE INJECTION LAYER, WHEREIN THE HOLE INJECTION LAYER COMPRISES A METAL COMPLEX OF FORMULA (I) AND A COMPOUND OF FORMULA (II), WHEREIN THE HOLE INJECTION LAYER IS ARRANGED BETWEEN THE ANODE LAYER AND THE AT LEAST ONE FIRST EMISSION LAYER | NOVALED GMBH (DE) | 2026-05-20 | — | — | EP | claimed |
| CN-122070479-A | Ultrasonic indicating device and method for monitoring ultrasonic treatment | JP实验室股份有限公司 | 2026-05-19 | — | — | CN | claimed |
| EP-4739300-A1 | MODULATORS OF IRON METABOLISM FOR TREATING CONDITIONS ASSOCIATED WITH CONE PHOTORECEPTOR DEGENERATION | SORBONNE UNIVERSITE (FR) | 2026-05-13 | — | — | EP | claimed |
| CN-122006800-A | Cu@TS-1 molecular sieve catalyst and preparation method and application thereof | 石河子大学 | 2026-05-12 | — | — | CN | claimed |
| EP-4735170-A1 | METATHESIS COMPOSITIONS COMPRISING AIR-STABLE IMIDO ALKYLIDENE COMPLEXES | Verbio SE (DE) | 2026-05-06 | — | — | EP | claimed |
| US-12618044-B2 | Specification of functional cranial placode derivatives from human pluripotent stem cells | MEMORIAL SLOAN-KETTERING CANCER CENTER (US) | 2026-05-05 | — | — | US | claimed |
| EP-3985750-B1 | LIGHT-EMITTING DEVICE AND APPARATUS INCLUDING THE SAME | SAMSUNG DISPLAY CO LTD (KR) | 2026-04-29 | — | — | EP | claimed |
| EP-4731209-A1 | PROCESSES FOR PREPARING SOLUBLE GUANYLATE CYCLASE STIMULATORS | Merck Sharp & Dohme LLC (US) | 2026-04-29 | — | — | EP | claimed |
| EP-3262055-B1 | WATER SOLUBLE FLUORESCENT OR COLORED DYES COMPRISING CONJUGATING GROUPS | SONY GROUP CORP (JP) | 2026-04-22 | — | — | EP | claimed |
| EP-4152422-B1 | AN ORGANIC ELECTRONIC DEVICE COMPRISING AN ANODE LAYER, A CATHODE LAYER, AT LEAST ONE PHOTOACTIVE LAYER, AND A SEMICONDUCTOR LAYER THAT COMPRISES A METAL COMPLEX | NOVALED GMBH (DE) | 2026-04-22 | — | — | EP | claimed |
| US-20220161245-A1 | Compositions And Methods For Infrared-Light-Controlled Ruthenium-Catalyzed Olefin Metathesis | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK | 2022-05-26 | — | — | US | claimed |
| EP-3356369-B1 | BENZIMIDAZOLO[1,2-A]BENZIMIDAZOLE CARRYING TRIAZINE GROUPS FOR ORGANIC LIGHT EMITTING DIODES | IDEMITSU KOSAN CO (JP) | 2022-05-04 | — | — | EP | claimed |
| EP-3778578-B1 | IMMUNOPROTEASOME INHIBITOR ANALOGS FOR TREATING INFLAMMATORY DISEASES | UNIV CALIFORNIA (US) | 2022-05-04 | — | — | EP | claimed |
| CN-114409876-A | Polymer for recognizing cadmium and zinc bimetallic ions and preparation method, application and analysis method thereof | 武汉工程大学 | 2022-04-29 | — | — | CN | claimed |
| EP-3042645-B1 | Dental composites with improved storage stability | IVOCLAR VIVADENT AG (LI) | 2022-04-27 | — | — | EP | claimed |
| EP-3976565-A1 | TUNGSTEN IMIDO ALKYLIDENE O-BITET AND O-BINOL COMPLEXES AND USE THEREOF IN OLEFIN METATHESIS REACTIONS | Verbio Vereinigte BioEnergie AG (DE) | 2022-04-06 | — | — | EP | claimed |
| WO-2022053965-A1 | NANOPARTICLES TO IMPROVE ANALYTICAL SIGNAL | ALMA MATER STUDIORUM - UNIVERSITA' DI BOLOGNA (IT) | 2022-03-17 | — | — | WO | claimed |
| EP-3962881-A1 | METHOD FOR RADIOIODINATION OR RADIOASTATINATION OF A BIOMOLECULE | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) | 2022-03-09 | — | — | EP | claimed |
| WO-2022029029-A1 | COMPOSITION AND METHOD FOR MODULATING FOOD INTAKE | UNIVERSITAT ROVIRA I VIRGILI (ES) | 2022-02-10 | — | — | WO | claimed |
| EP-3946480-A1 | TWO-COMPONENT SYSTEM FOR THE THERAPEUTIC TREATMENT OF SKIN LESIONS AND PRODUCTION METHOD THEREOF | DTech - Società a Responsabilità Limitata (IT) | 2022-02-09 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220161245-A1 | Compositions And Methods For Infrared-Light-Controlled Ruthenium-Catalyzed Olefin Metathesis | CYBB, CYBA, CYB5R3 | CCR1 3713/4885CCR8 3647/4885LMNA 4482/4885 |
| US-12618044-B2 | Specification of functional cranial placode derivatives from human pluripotent stem cells | BMP4, BMP1, PROX1 | CCR1 2064/4885CCR8 2246/4885LMNA 4175/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.